COc1cc2c(C(=O)N3CCN(c4cccc(C)c4)C(C)C3)cn(CC(C)C)c(=O)c2cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?